|
Market Closed -
Nasdaq
16:30:00 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 10.32 USD | -4.29% |
|
-7.53% | +21.55% |
| 09-28 | Polyrizon Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 09-22 | Polyrizon Ltd. Enrolls First Patient in U.S. Clinical Study of NASARIX (PL-14) Allergy Blocker | CI |
| Market Cap | 25.9M 23.04M 21.52M 19.63M 36.84M 2.49B 37.38M 260M 101M 1.27B 97.24M 95.13M 4.09B | P/E 2024 * |
-
| P/E 2025 | -1.73x |
|---|---|---|---|---|---|
| Enterprise Value | 13.44M 11.95M 11.17M 10.18M 19.11M 1.29B 19.4M 135M 52.29M 660M 50.45M 49.35M 2.12B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
99.28% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PLRZ | Delayed | |
CBOE
| PLRZ | Real-time |
| 1 day | -4.29% | ||
| 1 week | -7.53% | ||
| Current month | -4.29% | ||
| 1 month | -28.88% | ||
| 3 months | -17.57% | ||
| 6 months | -11.64% | ||
| Current year | +21.55% |
| 1 week | 10.08 |  | 11 |
| 1 month | 9.15 | | 14.96 |
| Current year | 8.23 | | 17.95 |
| 1 year | 2.88 | | 18.2 |
| 3 years | 2.88 | | 7,200 |
| 5 years | 2.88 | | 7,200 |
| 10 years | 2.88 | | 7,200 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tomer Izraeli
CEO | Chief Executive Officer | 48 | 2004-12-31 |
Nir Ben Yosef
DFI | Director of Finance/CFO | 51 | 2021-11-30 |
Tidhar Turgeman
CTO | Chief Tech/Sci/R&D Officer | 46 | 2020-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Tomer Izraeli
BRD | Director/Board Member | 48 | 2004-12-31 |
Oz Adler
CHM | Chairman | 39 | - |
Assaf Itzhaik
BRD | Director/Board Member | 54 | 2024-04-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/31/26 | Sell | Chairman | 3,292 | 0.2065% | ||
| 3/31/26 | Sell | Director | 942 | 0.0591% | ||
| 3/31/26 | Sell | Founder | 500 | 0.0314% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.29% | -7.53% | +59.26% | - | 25.9M | |
| +4.16% | -0.36% | +49.37% | +94.17% | 74.46B | |
| -0.61% | +0.69% | +36.36% | +82.72% | 60.14B | |
| -2.54% | -0.21% | +6.34% | +31.72% | 48.15B | |
| -3.02% | -2.67% | +37.26% | +32.51% | 44.25B | |
| +0.31% | +7.94% | +340.88% | +643.82% | 43.99B | |
| -1.96% | -1.71% | +5.30% | +99.46% | 41.61B | |
| +3.32% | +3.49% | +11.18% | +51.23% | 29.97B | |
| +4.77% | +6.16% | +36.77% | +22.78% | 29.31B | |
| -4.86% | -8.24% | -24.60% | +330.06% | 24.93B | |
| Average | -0.47% | +1.43% | +55.81% | +154.28% | 39.68B | |
| Weighted average by Cap. | +0.17% | +1.83% | +60.06% | +145.78% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.54M -1.37M -1.28M -1.17M -2.2M -149M -2.23M -15.52M -6.01M -75.85M -5.8M -5.67M -244M | -3.34M -2.97M -2.77M -2.53M -4.74M -321M -4.81M -33.5M -12.98M -164M -12.52M -12.25M -527M |
| Net Debt | -2.55M -2.27M -2.12M -1.94M -3.63M -246M -3.69M -25.66M -9.94M -125M -9.59M -9.38M -403M | -12.46M -11.09M -10.36M -9.44M -17.73M -1.2B -17.99M -125M -48.5M -612M -46.79M -45.78M -1.97B |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-01 | US$10.32 | -4.29% | 2,007 |
| 26-09-30 | US$10.78 | +2.79% | 13,525 |
| 26-09-29 | US$10.49 | +1.25% | 8,752 |
| 26-09-28 | US$10.36 | -3.85% | 4,473 |
| 26-09-25 | US$10.78 | +2.52% | 1,002 |
- Stock Market
- Stocks
- PLRZ Stock
Select your edition
All financial news and data tailored to specific country editions
